Adrien Celdran
Managing Director, Business Services Flagship
Realized
HRA Pharma
HRA Pharma is an innovative OTC pharma company with leading positions in Europe and in the US.
Overview
HRA Pharma is a European leader in emergency contraception, after developing the first levonorgestrel-based emergency contraceptive in 1999 and introducing the new generation product ellaOne, an ulipristal acetate-based emergency contraceptive, now available in over 80 countries worldwide. HRA Pharma also acquired several category-leading products, in particular two global leaders: Compeed, the leading blister treatment products and Mederma, the US category-leading scar-care treatment.
HRA Pharma also holds a strong and successful global franchise in the therapeutic area of rare endocrine diseases, with a particular focus on Cushing syndrome.
Head office
HRA Pharma has set up a commercial infrastructure across eleven European countries through seven subsidiaries and in the US.
Global sales
HRA Pharma has built a global distribution network for its products across 80 countries.
Healthcare sector2016 Entry into PortfolioFund Astorg VIHealthcare sector2016 Entry into PortfolioFund Astorg VIHealthcare sector2016 Entry into PortfolioFund Astorg VIHealthcare sector2016 Entry into PortfolioFund Astorg VIHealthcare sector2016 Entry into PortfolioFund Astorg VI
Meet the team behind our deep
expertise and market-leading results
Judith Charpentier
Co-Managing Partner and Co-Head Flagship
Olivier Lieven
Partner, Healthcare Flagship
Thierry Timsit
Executive Chairman
Recent News
ViewMore
Astorg and Goldman Sachs Asset Management announce they have received a binding offer and entered into exclusive negotiations with Perrigo for the sale of HRA Pharma.
Sep 8, 2021
ViewMore
HRA Pharma Acquires the Mederma® Brand from Merz Pharmaceuticals GmbH
Jun 27, 2019
ViewMore
HRA Pharma completes acquisition of Compeed®
Sep 25, 2017
ViewMore
HRA Pharma - David Wright's appointment
Jul 13, 2017
ViewMore
Astorg together with its co-investor Goldman Sachs Merchant Banking Division to acquire HRA Pharma
Feb 19, 2016
